Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity

about

Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity

Item

http://www.wikidata.org/entity/Q57160066

description

im Juni 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 June 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2018

@uk

name

Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity

@en

Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity

@nl

type

Item

label

Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity

@en

Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity

@nl

prefLabel

Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity

@en

Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity

@nl

P1476

Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity

@en

P2093

Arabella Young

http://www.w3.org/2001/XMLSchema#string

Arbi Abnousian

http://www.w3.org/2001/XMLSchema#string

Chien-Chun Pai

http://www.w3.org/2001/XMLSchema#string

David Wang

http://www.w3.org/2001/XMLSchema#string

Frederic Van Gool

http://www.w3.org/2001/XMLSchema#string

Jason Quiros

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Bluestone

http://www.w3.org/2001/XMLSchema#string

Lawrence Fong

http://www.w3.org/2001/XMLSchema#string

Michael D Rosenblum

http://www.w3.org/2001/XMLSchema#string

Michel DuPage

http://www.w3.org/2001/XMLSchema#string

P2860

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

Targeting EZH2 in cancer

Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses.

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

EZH2 as a mediator of treatment resistance in melanoma

Enhancement of antitumor immunity by CTLA-4 blockade

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Regulatory T cells and immune tolerance

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

P304

3262-3274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELREP.2018.05.050

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Massimiliano Pagani

Kelly Mahuron

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29898397

http://www.w3.org/2001/XMLSchema#string

P932

6094952

http://www.w3.org/2001/XMLSchema#string